Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Psychemedics Corporation, together with its subsidiaries, engages in the provision of testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples in the United States and internationally. It offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opioids, such as heroin metabolite, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, fentanyl and fentanyl analogs, and alcohol. The company's testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. It offers its services to employers for job applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. The company was incorporated in 1986 and is headquartered in Dallas, Texas. more
Time Frame | PMD | Sector | S&P500 |
---|
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 37.68M | 21.36M | 24.91M | 25.24M | 22.10M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":56.69,"profit":true},{"date":"2021-12-31","value":66.11,"profit":true},{"date":"2022-12-31","value":66.99,"profit":true},{"date":"2023-12-31","value":58.65,"profit":true}] |
Cost of Revenue | 21.23M | 16.47M | 14.64M | 15.95M | 13.69M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":77.58,"profit":true},{"date":"2021-12-31","value":68.97,"profit":true},{"date":"2022-12-31","value":75.11,"profit":true},{"date":"2023-12-31","value":64.45,"profit":true}] |
Gross Profit | 16.44M | 4.89M | 10.26M | 9.29M | 8.41M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":29.71,"profit":true},{"date":"2021-12-31","value":62.42,"profit":true},{"date":"2022-12-31","value":56.5,"profit":true},{"date":"2023-12-31","value":51.16,"profit":true}] |
Gross Margin | 43.64% | 22.87% | 41.21% | 36.81% | 38.07% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":52.41,"profit":true},{"date":"2021-12-31","value":94.41,"profit":true},{"date":"2022-12-31","value":84.34,"profit":true},{"date":"2023-12-31","value":87.23,"profit":true}] |
Operating Expenses | 13.45M | 10.95M | 10.05M | 10.37M | 11.33M | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":81.45,"profit":true},{"date":"2021-12-31","value":74.78,"profit":true},{"date":"2022-12-31","value":77.15,"profit":true},{"date":"2023-12-31","value":84.29,"profit":true}] |
Operating Income | 84.00K | (6.07M) | (3.48M) | (1.08M) | (2.92M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-7221.43,"profit":false},{"date":"2021-12-31","value":-4144.05,"profit":false},{"date":"2022-12-31","value":-1289.29,"profit":false},{"date":"2023-12-31","value":-3477.38,"profit":false}] |
Total Non-Operating Income/Expense | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Pre-Tax Income | 3.06M | (6.21M) | (821.00K) | (1.04M) | (3.44M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-203.08,"profit":false},{"date":"2021-12-31","value":-26.87,"profit":false},{"date":"2022-12-31","value":-34.03,"profit":false},{"date":"2023-12-31","value":-112.5,"profit":false}] |
Income Taxes | 1.51M | (2.35M) | (156.00K) | 44.00K | 716.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-155.02,"profit":false},{"date":"2021-12-31","value":-10.3,"profit":false},{"date":"2022-12-31","value":2.91,"profit":true},{"date":"2023-12-31","value":47.29,"profit":true}] |
Income After Taxes | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Income From Continuous Operations | 1.54M | (3.86M) | (665.00K) | (1.08M) | (3.90M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-250.26,"profit":false},{"date":"2021-12-31","value":-43.13,"profit":false},{"date":"2022-12-31","value":-70.3,"profit":false},{"date":"2023-12-31","value":-252.72,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 1.54M | (3.86M) | (665.00K) | (1.08M) | (4.15M) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-250.26,"profit":false},{"date":"2021-12-31","value":-43.13,"profit":false},{"date":"2022-12-31","value":-70.3,"profit":false},{"date":"2023-12-31","value":-269.39,"profit":false}] |
EPS (Diluted) | 0.28 | (0.70) | (0.13) | (0.19) | (0.72) | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-250,"profit":false},{"date":"2021-12-31","value":-46.43,"profit":false},{"date":"2022-12-31","value":-66.86,"profit":false},{"date":"2023-12-31","value":-257.89,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
PMD | |
---|---|
Cash Ratio | 0.37 |
Current Ratio | 1.59 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
PMD | |
---|---|
ROA (LTM) | -16.24% |
ROE (LTM) | -61.33% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
PMD | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.45 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.55 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
PMD | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.76 |
P/B | 2.40 |
Price/FCF | 64 |
EV/R | 0.65 |
EV/Ebitda | 12.91 |
Psychemedics Corporation (PMD) share price today is $
Yes, Indians can buy shares of Psychemedics Corporation (PMD) on Vested. To buy Psychemedics Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PMD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Psychemedics Corporation (PMD) via the Vested app. You can start investing in Psychemedics Corporation (PMD) with a minimum investment of $1.
You can invest in shares of Psychemedics Corporation (PMD) via Vested in three simple steps:
The 52-week high price of Psychemedics Corporation (PMD) is $3.64. The 52-week low price of Psychemedics Corporation (PMD) is $1.63.
The price-to-earnings (P/E) ratio of Psychemedics Corporation (PMD) is
The price-to-book (P/B) ratio of Psychemedics Corporation (PMD) is 2.40
The dividend yield of Psychemedics Corporation (PMD) is 0.00%
The market capitalization of Psychemedics Corporation (PMD) is $15.74M
The stock symbol (or ticker) of Psychemedics Corporation is PMD